The upcoming industry requirement for drug serialisation in the US and Europe cannot be ignored.
It is not a case of “if” or “when” but a case of how best to implement new systems and processes in time for the looming deadlines.
Carlos Machado, Serialisation Director at Zenith Technologies, explores the challenges, drivers and benefits around serialisation and discusses how to comply with the new regulations on-time, on-budget and with flawless execution.